Fig. 1: Overview of the study design.
From: Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge
A Flow chart of inclusion and exclusion for COVID-19 patients enrolled in this study. B Schematic summary of the study design and patient cohort. C PCA plot of the proteomics data from the plasma samples. Each dot represents one plasma sample, color-coded for the different groups. Green, yellow, and red data points are healthy control subjects and non-severe and severe COVID-19 survivors at 6 months after discharge, respectively. D PCA plot of the metabolomics data from the plasma samples. Each dot represents one plasma sample, color-coded for the different groups as described for panel (C).
